Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United States Antimony (UAMY) Common Equity (2016 - 2025)

United States Antimony (UAMY) has disclosed Common Equity for 15 consecutive years, with $141.0 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 392.84% to $141.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $141.0 million through Dec 2025, up 392.84% year-over-year, with the annual reading at $141.0 million for FY2025, 392.84% up from the prior year.
  • Common Equity hit $141.0 million in Q4 2025 for United States Antimony, up from $71.8 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $141.0 million in Q4 2025 to a low of $25.1 million in Q3 2024.
  • Historically, Common Equity has averaged $38.3 million across 5 years, with a median of $32.1 million in 2021.
  • Biggest five-year swings in Common Equity: decreased 19.92% in 2023 and later soared 392.84% in 2025.
  • Year by year, Common Equity stood at $32.4 million in 2021, then dropped by 1.54% to $31.9 million in 2022, then dropped by 19.92% to $25.5 million in 2023, then grew by 12.07% to $28.6 million in 2024, then skyrocketed by 392.84% to $141.0 million in 2025.
  • Business Quant data shows Common Equity for UAMY at $141.0 million in Q4 2025, $71.8 million in Q3 2025, and $37.5 million in Q2 2025.